New Study to Get More Minorities Involved in Genetic Testing
1046 articles
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
Terms of Use
Copyright The entire content included in this Website, letswinpc.org, including but not limited to text, graphics, or code, is copyrighted as a collective work under the United States’ and other copyright laws, and is the property of Let’s Win. The collective work includes works that are licensed to Let’s Win. ALL RIGHTS RESERVED. You may […]
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
2024 TCS New York City Marathon
Sunday, November 3rd, 2024 We are honored to be an official charity partner of the New York Road Runners (NYRR) and are grateful for your support. On November 3rd, 2024, Team Let’s Win will take on New York City for the marathon. Meet Our Team Our runners come from all over the country united by […]
Pancreatic Cancer Basics
Learn the Basics Getting diagnosed with pancreatic cancer is overwhelming. Besides not feeling well, you are thrown into a world with treatments, procedures, and words you don’t know, while facing major decisions and a very serious disease. Here you can find comprehensive explanations, including different treatments and questions to ask. To learn more about first […]
Oncologists Are Struggling to Treat Cancer Patients Amid the Pandemic
Dr. Allyson Ocean explains the changes to her practice and risks she and her patients face as they battle cancer amid the COVID-19 pandemic.
A Platinum Remembrance: The Power of Raising Your Voice
Gil Bashe and John Bianchi share a remembrance of Anne Glauber’s work and the power of advocacy on the eve of the Platinum PR Awards.
Diet and Nutrition
Managing Your Diet Learn more about what to eat and how to eat during treatment and after. We know good nutrition is vital to your overall health, but it’s even more important when you have pancreatic cancer. That’s because the cancer disrupts your body’s ability to break down and absorb nutrients from the food you […]
About Us
Let’s Win Pancreatic Cancer plays a critical role in getting research to patients, to transform outcomes. Our wealth of readily accessible patient-centered resources includes stories that highlight the latest research in the field, a clinical trial finder, and a doctor finder. Available in English and Spanish, our tools empower patients and caregivers to make informed […]
Amazing Things—Dr. Allyson Ocean
Dr. Allyson Ocean is known for her warmth, and in a promotional video for NewYork-Presbyterian, former patient Corrine Cole explains why.
Hope For All Stages
The doctors and researchers at the Penn Pancreatic Cancer Research Center examine different aspects of pancreatic cancer to find better treatments.
Let’s Win Pancreatic Cancer: Leading the Way Forward for Patients
The Biden Cancer Initiative has launched Pulse on Progress, an online magazine on Medium, and Let’s Win is featured in the first edition. The article focuses on how Let’s Win is changing the narrative around pancreatic cancer.
Treatment Options
Treatment Options After you are diagnosed, your oncologist will discuss treatments. Learn more about the different types of chemotherapy, surgery, and radiation used to treat pancreatic cancer. Chemotherapy Most pancreatic cancer patients receive some type of chemotherapy, no matter what the stage of disease, to stop or slow the cancer from growing. Chemotherapy can cause […]
Finding a Clinical Trial
Let’s Win’s Trial Finder Clinical trials are important to consider for pancreatic cancer patients at all stages of the disease. Trials provide access to cutting-edge treatments not yet widely available, offering hope and potentially better outcomes. Studies are taking place at numerous locations across the United States, making participation more accessible than ever. Let’s Win […]
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.